117 related articles for article (PubMed ID: 28798401)
1. The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells.
Liu CY; Huang TT; Chu PY; Huang CT; Lee CH; Wang WL; Lau KY; Tsai WC; Chao TI; Su JC; Chen MH; Shiau CW; Tseng LM; Chen KF
Exp Mol Med; 2017 Aug; 49(8):e366. PubMed ID: 28798401
[TBL] [Abstract][Full Text] [Related]
2. Sorafenib analogue SC-60 induces apoptosis through the SHP-1/STAT3 pathway and enhances docetaxel cytotoxicity in triple-negative breast cancer cells.
Liu CY; Su JC; Huang TT; Chu PY; Huang CT; Wang WL; Lee CH; Lau KY; Tsai WC; Yang HP; Shiau CW; Tseng LM; Chen KF
Mol Oncol; 2017 Mar; 11(3):266-279. PubMed ID: 28084011
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting with DABIL-4 depletes myeloid suppressor cells in 4T1 triple-negative breast cancer model.
Parveen S; Siddharth S; Cheung LS; Kumar A; Shen J; Murphy JR; Sharma D; Bishai WR
Mol Oncol; 2021 May; 15(5):1330-1344. PubMed ID: 33682324
[TBL] [Abstract][Full Text] [Related]
4. Ononin triggers ferroptosis-mediated disruption in the triple negative breast cancer both in vitro and in vivo.
Gong G; Wan Y; Liu Y; Zhang Z; Zheng Y
Int Immunopharmacol; 2024 May; 132():111959. PubMed ID: 38554442
[TBL] [Abstract][Full Text] [Related]
5. In silico identification of a novel Cdc2-like kinase 2 (CLK2) inhibitor in triple negative breast cancer.
Huang CC; Hsu CM; Chao MW; Hsu KC; Lin TE; Yen SC; Tu HJ; Pan SL
Protein Sci; 2024 Jun; 33(6):e5004. PubMed ID: 38723164
[TBL] [Abstract][Full Text] [Related]
6. Bifunctional HDAC and DNMT inhibitor induces viral mimicry activates the innate immune response in triple-negative breast cancer.
Fan W; Li W; Li L; Qin M; Mao C; Yuan Z; Wang P; Chu B; Jiang Y
Eur J Pharm Sci; 2024 Jun; 197():106767. PubMed ID: 38636781
[TBL] [Abstract][Full Text] [Related]
7. Aberrant TIMP-1 production in tumor-associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma.
Duch P; Díaz-Valdivia N; Gabasa M; Ikemori R; Arshakyan M; Fernández-Nogueira P; Llorente A; Teixido C; Ramírez J; Pereda J; Chuliá-Peris L; Galbis JM; Hilberg F; Reguart N; Radisky DC; Alcaraz J
Cancer Sci; 2024 May; 115(5):1505-1519. PubMed ID: 38476010
[TBL] [Abstract][Full Text] [Related]
8. Benzo[
Guerra FS; Dias FRF; Cunha AC; Fernandes PD
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361566
[TBL] [Abstract][Full Text] [Related]
9. LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer.
Li M; Viswanadhapalli S; Santhamma B; Pratap UP; Luo Y; Liu J; Altwegg KA; Tang W; Liu Z; Li X; Ebrahimi B; Yan H; Zou Y; Konda S; Sareddy GR; Xu Z; Chen Y; Rao MK; Brenner AJ; Kaklamani VG; Tekmal RR; Ahmed G; Raj GV; Nickisch KJ; Nair HB; Vadlamudi RK
Commun Biol; 2021 Oct; 4(1):1235. PubMed ID: 34716410
[TBL] [Abstract][Full Text] [Related]
10. Potential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative breast cancer.
Long L; Fei X; Chen L; Yao L; Lei X
Front Oncol; 2024; 14():1381251. PubMed ID: 38699644
[TBL] [Abstract][Full Text] [Related]
11. Nintedanib ameliorates animal model of dermatitis.
Heo MJ; Lee C; Choi SY; Choi YM; An IS; Bae S; An S; Jung JH
Sci Rep; 2020 Mar; 10(1):4493. PubMed ID: 32161331
[TBL] [Abstract][Full Text] [Related]
12. Kaempferide triggers apoptosis and paraptosis in pancreatic tumor cells by modulating the ROS production, SHP-1 expression, and the STAT3 pathway.
Jung YY; Son NT; Mohan CD; Bastos JK; Luyen ND; Huong LM; Ahn KS
IUBMB Life; 2024 May; ():. PubMed ID: 38708996
[TBL] [Abstract][Full Text] [Related]
13. Deciphering the Biological Activities of
Elleuch F; Baril P; Barkallah M; Perche F; Abdelkafi S; Fendri I; Pichon C
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138292
[TBL] [Abstract][Full Text] [Related]
14. Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Kim SB; Dent R; Im SA; Espié M; Blau S; Tan AR; Isakoff SJ; Oliveira M; Saura C; Wongchenko MJ; Kapp AV; Chan WY; Singel SM; Maslyar DJ; Baselga J;
Lancet Oncol; 2017 Oct; 18(10):1360-1372. PubMed ID: 28800861
[TBL] [Abstract][Full Text] [Related]
15. MAP2K1 Mutation in Colorectal Cancer Patients: Therapeutic Challenge Using Patient-Derived Tumor Cell Lines.
Kim JE; Kim KK; Kim SY; Lee J; Park SH; Park JO; Park YS; Lim HY; Kang WK; Kim ST
J Cancer; 2017; 8(12):2263-2268. PubMed ID: 28819429
[No Abstract] [Full Text] [Related]
16. Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells.
Liu CY; Lau KY; Hsu CC; Chen JL; Lee CH; Huang TT; Chen YT; Huang CT; Lin PH; Tseng LM
PLoS One; 2017; 12(12):e0189007. PubMed ID: 29261702
[TBL] [Abstract][Full Text] [Related]
17. Single-nucleotide polymorphisms in the genes of CES2, CDA and enzymatic activity of CDA for prediction of the efficacy of capecitabine-containing chemotherapy in patients with metastatic breast cancer.
Lam SW; van der Noort V; van der Straaten T; Honkoop AH; Peters GJ; Guchelaar HJ; Boven E
Pharmacol Res; 2018 Feb; 128():122-129. PubMed ID: 28827188
[TBL] [Abstract][Full Text] [Related]
18. Musashi-1 Enhances Glioblastoma Cell Migration and Cytoskeletal Dynamics through Translational Inhibition of Tensin3.
Chen HY; Lin LT; Wang ML; Laurent B; Hsu CH; Pan CM; Jiang WR; Chen PY; Ma HI; Chen YW; Huang PI; Chiou A; Chiou SH
Sci Rep; 2017 Aug; 7(1):8710. PubMed ID: 28821879
[TBL] [Abstract][Full Text] [Related]
19. Metastatic melanoma: prognostic factors and survival in patients with brain metastases.
Frinton E; Tong D; Tan J; Read G; Kumar V; Kennedy S; Lim C; Board RE
J Neurooncol; 2017 Dec; 135(3):507-512. PubMed ID: 28819707
[TBL] [Abstract][Full Text] [Related]
20. Intercalating and maintenance gefitinib plus chemotherapy versus chemotherapy alone in selected advanced non-small cell lung cancer with unknown EGFR status.
Jian H; Li W; Ma Z; Huang J; Feng J; Song Y; Gao B; Zhu H; Tao M; Bai C; Ma S; Pan H; Qin S; Hua D; Yu Y; Lu S
Sci Rep; 2017 Aug; 7(1):8483. PubMed ID: 28814805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
